These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 21496949)

  • 1. A randomized controlled trial of oral phosphate binders in the treatment of pseudoxanthoma elasticum.
    Yoo JY; Blum RR; Singer GK; Stern DK; Emanuel PO; Fuchs W; Phelps RG; Terry SF; Lebwohl MG
    J Am Acad Dermatol; 2011 Aug; 65(2):341-348. PubMed ID: 21496949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ectopic mineralization of connective tissue in Abcc6-/- mice: effects of dietary modifications and a phosphate binder--a preliminary study.
    LaRusso J; Jiang Q; Li Q; Uitto J
    Exp Dermatol; 2008 Mar; 17(3):203-7. PubMed ID: 17979973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnesium supplementation in the treatment of pseudoxanthoma elasticum: A randomized trial.
    Rose S; On SJ; Fuchs W; Chen C; Phelps R; Kornreich D; Haddican M; Singer G; Wong V; Baum D; Vekaria A; Gagliotti M; Huang R; Suárez-Fariñas M; Terry SF; Lebwohl M
    J Am Acad Dermatol; 2019 Jul; 81(1):263-265. PubMed ID: 30826287
    [No Abstract]   [Full Text] [Related]  

  • 4. Mammographic findings in pseudoxanthoma elasticum.
    Bercovitch L; Schepps B; Koelliker S; Magro C; Terry S; Lebwohl M
    J Am Acad Dermatol; 2003 Mar; 48(3):359-66. PubMed ID: 12637915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral phosphate binders in the treatment of pseudoxanthoma elasticum.
    Sherer DW; Singer G; Uribarri J; Phelps RG; Sapadin AN; Freund KB; Yanuzzi L; Fuchs W; Lebwohl M
    J Am Acad Dermatol; 2005 Oct; 53(4):610-5. PubMed ID: 16198780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The real-world dose-relativity of sevelamer hydrochloride and lanthanum carbonate monotherapy in patients with end-stage renal disease.
    Wilson RJ; Keith MS; Preston P; Copley JB
    Adv Ther; 2013 Dec; 30(12):1100-10. PubMed ID: 24307220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudoxanthoma elasticum (PXE)-like calcification in adult dermatomyositis.
    Gushi A; Kanekura T; Mochitomi Y; Kawabata H; Kanzaki T
    J Dermatol; 2002 Jul; 29(7):423-6. PubMed ID: 12184640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnesium carbonate-containing phosphate binder prevents connective tissue mineralization in Abcc6(-/-) mice-potential for treatment of pseudoxanthoma elasticum.
    Li Q; Larusso J; Grand-Pierre AE; Uitto J
    Clin Transl Sci; 2009 Dec; 2(6):398-404. PubMed ID: 20443931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etidronate for Prevention of Ectopic Mineralization in Patients With Pseudoxanthoma Elasticum.
    Kranenburg G; de Jong PA; Bartstra JW; Lagerweij SJ; Lam MG; Ossewaarde-van Norel J; Risseeuw S; van Leeuwen R; Imhof SM; Verhaar HJ; de Vries JJ; Slart RHJA; Luurtsema G; den Harder AM; Visseren FLJ; Mali WP; Spiering W
    J Am Coll Cardiol; 2018 Mar; 71(10):1117-1126. PubMed ID: 29519353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis.
    Block GA; Spiegel DM; Ehrlich J; Mehta R; Lindbergh J; Dreisbach A; Raggi P
    Kidney Int; 2005 Oct; 68(4):1815-24. PubMed ID: 16164659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of morbidity and mortality data related to cardiovascular calcification from calcium-containing phosphate binder use in patients undergoing hemodialysis.
    Mason MA; Shepler BM
    Pharmacotherapy; 2010 Jul; 30(7):741-8. PubMed ID: 20575637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of sevelamer hydrochloride with calcium acetate on biomarkers of bone turnover in hemodialysis patients.
    Liu YL; Lin HH; Yu CC; Kuo HL; Yang YF; Chou CY; Lin PW; Liu JH; Liao PY; Huang CC
    Ren Fail; 2006; 28(8):701-7. PubMed ID: 17162430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, parallel, open-label study to compare once-daily sevelamer carbonate powder dosing with thrice-daily sevelamer hydrochloride tablet dosing in CKD patients on hemodialysis.
    Fishbane S; Delmez J; Suki WN; Hariachar SK; Heaton J; Chasan-Taber S; Plone MA; Moe S
    Am J Kidney Dis; 2010 Feb; 55(2):307-15. PubMed ID: 20042256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early arterial calcification does not correlate with bone loss in pseudoxanthoma elasticum.
    Martin L; Hoppé E; Kauffenstein G; Omarjee L; Navasiolava N; Henni S; Willoteaux S; Leftheriotis G
    Bone; 2017 Oct; 103():88-92. PubMed ID: 28658601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous lowering of serum phosphate and LDL-cholesterol by sevelamer hydrochloride (RenaGel) in dialysis patients.
    Wilkes BM; Reiner D; Kern M; Burke S
    Clin Nephrol; 1998 Dec; 50(6):381-6. PubMed ID: 9877112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of sevelamer hydrochloride and calcium carbonate on renal osteodystrophy in hemodialysis patients.
    Ferreira A; Frazão JM; Monier-Faugere MC; Gil C; Galvao J; Oliveira C; Baldaia J; Rodrigues I; Santos C; Ribeiro S; Hoenger RM; Duggal A; Malluche HH;
    J Am Soc Nephrol; 2008 Feb; 19(2):405-12. PubMed ID: 18199805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of sevelamer and calcium-based phosphate binders on coronary artery calcification and accumulation of circulating advanced glycation end products in hemodialysis patients.
    Kakuta T; Tanaka R; Hyodo T; Suzuki H; Kanai G; Nagaoka M; Takahashi H; Hirawa N; Oogushi Y; Miyata T; Kobayashi H; Fukagawa M; Saito A
    Am J Kidney Dis; 2011 Mar; 57(3):422-31. PubMed ID: 21239096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of etidronate on choroidal neovascular activity in patients with pseudoxanthoma elasticum.
    Risseeuw S; van Leeuwen R; Imhof SM; de Jong PA; Mali WPTM; Spiering W; Ossewaarde-van Norel J
    PLoS One; 2020; 15(10):e0240970. PubMed ID: 33079965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyrophosphates as a major inhibitor of matrix calcification in Pseudoxanthoma elasticum.
    Dabisch-Ruthe M; Kuzaj P; Götting C; Knabbe C; Hendig D
    J Dermatol Sci; 2014 Aug; 75(2):109-20. PubMed ID: 24907773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.